Published in Dalton Trans on August 05, 2010
Supramolecular coordination: self-assembly of finite two- and three-dimensional ensembles. Chem Rev (2011) 1.76
Hexanuclear self-assembled arene-ruthenium nano-prismatic cages: potential anticancer agents. Chem Commun (Camb) (2011) 0.95
In vivo anticancer activity of rhomboidal Pt(II) metallacycles. Proc Natl Acad Sci U S A (2014) 0.84
Self-assembly of Cationic, Hetero- or Homo-nuclear Ru(II) Macrocyclic Rectangles and their Photophysical, Electrochemical and Biological Studies. Organometallics (2011) 0.80
Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger. Nanoscale (2017) 0.77
The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. Chem Soc Rev (2017) 0.75
Coordination assemblies from a Pd(II)-cornered square complex. Acc Chem Res (2005) 2.72
Self-assembled M24L48 polyhedra and their sharp structural switch upon subtle ligand variation. Science (2010) 2.09
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis. Sci Transl Med (2012) 1.78
Efficient dehydrogenation of formic acid using an iron catalyst. Science (2011) 1.71
Bioorganometallic chemistry--from teaching paradigms to medicinal applications. Chem Soc Rev (2008) 1.64
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes. J Med Chem (2005) 1.35
Solvent-induced polymorphism of three-dimensional hydrogen-bonded networks of hexakis(4-carbamoylphenyl)benzene. J Am Chem Soc (2003) 1.31
From dysfunction to bis-function: on the design and applications of functionalised ionic liquids. Chemistry (2006) 1.31
Tobacco smoke induces CYP1B1 in the aerodigestive tract. Carcinogenesis (2004) 1.30
Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity. Inorg Chem (2007) 1.30
Towards a new combination therapy for tuberculosis with next generation benzothiazinones. EMBO Mol Med (2014) 1.27
KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients. Chem Biodivers (2008) 1.27
Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. Am J Physiol Gastrointest Liver Physiol (2005) 1.24
Design and synthesis of a novel magnetic resonance imaging contrast agent for selective sensing of zinc ion. Chem Biol (2002) 1.23
Ionic solid-state dimers and polymers derived from imidazolium dicarboxylic acids. Chemistry (2006) 1.22
Targeted and multifunctional arene ruthenium chemotherapeutics. Dalton Trans (2011) 1.21
Finite, spherical coordination networks that self-organize from 36 small components. Angew Chem Int Ed Engl (2004) 1.20
Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials (2009) 1.19
Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound. Int J Oncol (2008) 1.18
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance. J Am Chem Soc (2005) 1.17
Novel molecular drug carrier: encapsulation of oxaliplatin in cucurbit[7]uril and its effects on stability and reactivity of the drug. Org Biomol Chem (2005) 1.13
Enantio- and diastereoselective catalytic Mannich-type reaction of a glycine schiff base using a chiral two-center phase-transfer catalyst. Angew Chem Int Ed Engl (2005) 1.13
The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways. J Biol Inorg Chem (2008) 1.11
The "complex-in-a-complex" cations [(acac)2M subset Ru6(p-iPrC6H4Me)6(tpt)2(dhbq)3]6+: A trojan horse for cancer cells. Angew Chem Int Ed Engl (2008) 1.10
Selective Inclusion of a Hetero-Guest Pair in a Molecular Host: Formation of Stable Charge-Transfer Complexes in Cucurbit Angew Chem Int Ed Engl (2001) 1.10
Highly cytotoxic copper(II) complexes with modified paullone ligands. Inorg Chem (2010) 1.09
Brønsted acidic ionic liquids and their zwitterions: synthesis, characterization and pKa determination. Chemistry (2004) 1.09
Intramolecular nonbonded S...N interaction in rabeprazole. Chem Pharm Bull (Tokyo) (2008) 1.07
An internal fluorescent probe based on anthracene to evaluate cation-anion interactions in imidazolium salts. Chemistry (2010) 1.07
DNA and RNA as new binding targets of green tea catechins. J Biol Chem (2006) 1.06
Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action. J Inorg Biochem (2007) 1.06
Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents. Dalton Trans (2010) 1.05
Revisiting the electronic structure of phosphazenes. Inorg Chem (2005) 1.05
Direct catalytic asymmetric aldol reaction of hydroxyketones: asymmetric Zn catalysis with a Et(2)Zn/linked-BINOL complex. J Am Chem Soc (2003) 1.05
Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential. J Biol Inorg Chem (2012) 1.03
Spontaneous resolution of aromatic sulfonamides: effective screening method and discrimination of absolute structure. Org Lett (2006) 1.00
A well-defined iron catalyst for the reduction of bicarbonates and carbon dioxide to formates, alkyl formates, and formamides. Angew Chem Int Ed Engl (2010) 0.98
NMR, PGSE diffusion, and X-ray diffraction studies of lithium and potassium salts derived from diphenylphosphino(o-cyanophenyl)aniline and their crown ether complexes. Inorg Chem (2005) 0.97
Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem (2011) 0.97
A viable hydrogen-storage system based on selective formic acid decomposition with a ruthenium catalyst. Angew Chem Int Ed Engl (2008) 0.96
Amide conformational switching induced by protonation of aromatic substituent. Org Lett (2003) 0.96
Metal-based antitumour drugs in the post-genomic era: what comes next? Dalton Trans (2011) 0.95
Osmotic regulation of the Streptomyces lividans thiostrepton-inducible promoter, ptipA. Microbiology (2002) 0.95
transformation between diphosphinoamines and iminobiphosphines: a reversible P-N-P <--> N=P-P rearrangement triggered by protonation/deprotonation. Inorg Chem (2004) 0.95
Carbohydrate-metal complexes and their potential as anticancer agents. Curr Med Chem (2008) 0.95
Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach. Inorg Chem (2007) 0.95
Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds. J Med Chem (2008) 0.95
Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands. Dalton Trans (2010) 0.94
Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide. Bioorg Med Chem (2010) 0.94
Chiral Lewis Acid-Mediated Enantioselective Pictet-Spengler Reaction of N(b)-Hydroxytryptamine with Aldehydes. J Org Chem (1998) 0.94
Rewritable phosphorescent paper by the control of competing kinetic and thermodynamic self-assembling events. Nat Mater (2005) 0.94
Selective formic acid decomposition for high-pressure hydrogen generation: a mechanistic study. Chemistry (2009) 0.93
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin. Lung Cancer (2008) 0.93
A cytotoxic ruthenium tris(bipyridyl) complex that accumulates at plasma membranes. Chembiochem (2009) 0.92
A ruthenium antimetastasis agent forms specific histone protein adducts in the nucleosome core. Chemistry (2011) 0.92
Transposon Express, a software application to report the identity of insertions obtained by comprehensive transposon mutagenesis of sequenced genomes: analysis of the preference for in vitro Tn5 transposition into GC-rich DNA. Nucleic Acids Res (2004) 0.92
Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin. Metallomics (2011) 0.91
Determination of drug binding sites to proteins by electrospray ionisation mass spectrometry: the interaction of cisplatin with transferrin. Rapid Commun Mass Spectrom (2002) 0.91
Naphthalene- and anthracene-based aromatic foldamers with iminodicarbonyl linkers: their stabilities and application to a chiral photochromic system using retro [4 + 4] cycloaddition. J Org Chem (2006) 0.91
Synthesis and (spectro)electrochemistry of mixed-valent diferrocenyl-dihydrothiopyran derivatives. Dalton Trans (2015) 0.91
Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties. J Med Chem (2010) 0.90
Dielectric response of imidazolium-based room-temperature ionic liquids. J Phys Chem B (2006) 0.90
Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci (2005) 0.90
Solution self-assembly, spontaneous deprotonation, and crystal structures of bipyrazolate-bridged metallomacrocycles with dimetal centers. Inorg Chem (2005) 0.90
Aromatic foldamers with iminodicarbonyl linkers: their structures and optical properties. J Org Chem (2005) 0.90
Structure and reaction pathway of TMP-Zincate: amido base or alkyl base? J Am Chem Soc (2006) 0.90
Sequence-selective recognition of peptides within the single binding pocket of a self-assembled coordination cage. J Am Chem Soc (2005) 0.90
Novel Pseudorotaxane-Terminated Dendrimers: Supramolecular Modification of Dendrimer Periphery We gratefully acknowledge the Korean Ministry of Science and Technology (Creative Research Initiative Program) for support of this work, and Professor P. K. Bharadwaj for reading the manuscript. Angew Chem Int Ed Engl (2001) 0.90
Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms. J Med Chem (2007) 0.90
Biological studies of chalcogenolato-bridged dinuclear half-sandwich complexes. Inorg Chem (2013) 0.90
Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors. Biomaterials (2011) 0.90
CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP. J Inorg Biochem (2007) 0.89
Organometallic ruthenium(II) arene compounds with antiangiogenic activity. J Med Chem (2011) 0.89
Iodomesitylene-catalyzed oxidative cleavage of carbon-carbon double and triple bonds using m-chloroperbenzoic acid as a terminal oxidant. J Am Chem Soc (2009) 0.89
A low-grade myofibroblastic sarcoma in the abdominal cavity. Anticancer Res (2011) 0.89
Macrocycles within Macrocycles: Cyclen, Cyclam, and Their Transition Metal Complexes Encapsulated in Cucurbit Angew Chem Int Ed Engl (2001) 0.89
Design, synthesis, and biological activity of folate receptor-targeted prodrugs of thiolate histone deacetylase inhibitors. Bioorg Med Chem Lett (2007) 0.89
Evaluation of energy transfer in perylene-cored anthracene dendrimers. Chem Commun (Camb) (2006) 0.89
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake. J Med Chem (2005) 0.89
An evaluation of amide group planarity in 7-azabicyclo[2.2.1]heptane amides. Low amide bond rotation barrier in solution. J Am Chem Soc (2003) 0.89
Complete selection of a self-assembling homo- or hetero-cavitand cage via metal coordination based on ligand tuning. J Am Chem Soc (2004) 0.88
Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound. J Biol Inorg Chem (2009) 0.88
Dimethylthioarsenicals as arsenic metabolites and their chemical preparations. Chem Res Toxicol (2004) 0.88